Inventories (Tables)

6 Months Ended

Jun. 30, 2015

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventories consist of the following:	(in thousands)
	June 30,			December 31,
	2015			2014
Inventory work-in-process, January 1	$	—		$	—
Production(1)	1,126			—
Spoilage	(117		)	—
Inventory work-in-process, end of period	$	1,009		$	—

(1) Commercial sales of Alferon® will not resume until new batches of commercial filled and finished product are produced and released by the FDA. We are continuing the validation of Alferon® production and production of new Alferon® API inventory commenced in February 2015. While the facility is approved by the FDA under the Biological License Application (“BLA”) for Alferon®, this status will need to be reaffirmed by an FDA pre-approval inspection. The Company will also need the FDA’s approval to release commercial product once it has submitted satisfactory stability and quality release data.